DCAF12

DCAF12 is the substrate-receptor subunit of a CUL4-DDB1 (CRL4) E3 ubiquitin ligase that recognizes substrates through a C-terminal acidic di-glutamate degron and directs their proteasomal degradation to regulate diverse cellular processes (PMID:34065512, PMID:36715408). Structurally, DCAF12 uses a WD40 β-propeller with a positively charged central pocket to engage the C-terminal di-Glu motif, binding degron peptides of CCT5 and MAGEA3 with nanomolar affinity (PMID:36715408, PMID:38665159). Through this degron-recognition mechanism CRL4DCAF12 degrades MAGE-A3/6 in response to nutrient deprivation to enable starvation-induced autophagy (PMID:31267705), degrades the RNA helicase MOV10 — a function required in mice for normal spermatogenesis and T cell activation (PMID:34065512), degrades monomeric (but not TRiC-assembled) CCT5 as a chaperonin assembly quality-control step (PMID:36715408), and degrades MCMBP to license incorporation of MCM2 into MCM2-7 complexes, preventing replication stress (PMID:41145411). Beyond canonical degradation, DCAF12 catalyzes non-degradative ubiquitination of TRiC/CCT subunits that enhances chaperonin folding of cytoskeletal and oncogenic clients and activates YAP, STAT3, and mTOR signaling to promote lung cancer metastasis (PMID:41047465). Independently of its ligase role, DCAF12 acts as an IAP antagonist: it binds the BIR domains of XIAP, cIAP1/2, and BRUCE and, upon apoptotic stimuli, translocates from nucleus to cytoplasm to block XIAP–caspase interactions and facilitate caspase activation, a function conserved in Drosophila where DCAF12 is required for IAP cleavage and RHG-mediated apoptosis (PMID:26972874, PMID:35459779). In Drosophila it also functions as a Cul4 cofactor at synapses, controlling neurotransmitter release and glutamate receptor abundance (PMID:30670470).

1. 2008 Low

   Initial characterization placed the cancer-testis antigen TCC52/DCAF12 at a subcellular location, providing a first physical anchor before any biochemical function was known.

   Evidence Subcellular immunostaining in a cancer-testis antigen study

   PMID:18957058

   Open questions at the time

   • Single localization observation without functional follow-up
   • No link to ubiquitin ligase activity established
   • Centrosomal localization not corroborated by later mechanistic studies
2. 2016 Medium

   Drosophila genetics established that DCAF12 is required for apoptosis, showing it is necessary and sufficient for RHG-mediated death and limits tumor growth, but left the molecular mechanism open.

   Evidence Drosophila loss-of-function, apoptosis assays, genetic epistasis with pro-apoptotic and tumor suppressor genes

   PMID:26972874

   Open questions at the time

   • Direct biochemical mechanism for IAP cleavage not defined
   • Single model organism
   • Relationship to ubiquitin ligase activity unresolved
3. 2019 Medium

   Identification of CRL4-DCAF12 as the E3 ligase degrading MAGE-A3/6 under starvation defined DCAF12 as a substrate receptor coupling protein degradation to autophagy regulation.

   Evidence Proteomic interactor analysis, proteasome inhibitor assays, complex identification, autophagy functional assays

   PMID:31267705

   Open questions at the time

   • Degron recognition basis not yet structurally resolved
   • Single lab
   • Physiological scope beyond starvation unclear
4. 2019 High

   Synaptic studies in Drosophila showed DCAF12 acts as a Cul4 cofactor with distinct pre- and postsynaptic roles, broadening its function beyond apoptosis to neuronal regulation.

   Evidence Genetic deletion, tissue-specific rescue, NMJ electrophysiology, epistasis with Cul4

   PMID:30670470

   Open questions at the time

   • Synaptic substrates of CRL4DCAF12 not identified
   • Conservation in mammalian neurons untested
5. 2021 High

   Discovery of MOV10 as a substrate recognized via a C-terminal acidic degron, combined with knockout mice, tied DCAF12-mediated degradation to RNA silencing control and in vivo phenotypes in spermatogenesis and T cell activation.

   Evidence Reciprocal complex purification, CRL dependence assays, Dcaf12 knockout mice, protein-level and phenotypic analysis

   PMID:34065512

   Open questions at the time

   • Atomic basis of degron recognition not resolved here
   • Full substrate repertoire in vivo unknown
6. 2023 High

   A cryo-EM structure of DDB1-DCAF12-CCT5 explained substrate selection at near-atomic resolution and revealed assembly-state-dependent ubiquitination, establishing CRL4DCAF12 in chaperonin assembly quality control.

   Evidence 2.8 Å cryo-EM structure, reconstituted ubiquitination of monomeric vs. assembled CCT5, degron-contact mutagenesis

   PMID:36715408

   Open questions at the time

   • How DCAF12 discriminates monomeric from assembled CCT5 mechanistically
   • In vivo consequences of CCT5 degradation not fully mapped
7. 2024 High

   A second structure with MAGEA3 plus biophysical/cellular binding assays generalized the di-Glu degron recognition mechanism across substrates, defining the receptor residues and nanomolar binding affinities.

   Evidence 3.17 Å cryo-EM structure, NanoBRET, in vitro and cellular biophysical binding assays

   PMID:38665159

   Open questions at the time

   • Degron prediction across the full substrate space not completed
   • Single lab
8. 2025 High

   Identification of MCMBP as a CRL4DCAF12 substrate connected the ligase to MCM2-7 assembly and DNA replication licensing, with loss causing replication stress.

   Evidence Substrate identification, KO cells, chromatin fractionation, DNA fiber assays, replication stress markers

   PMID:41145411

   Open questions at the time

   • Whether MCMBP carries a canonical di-Glu degron not stated
   • Cell-cycle regulation of this activity unknown
9. 2025 Medium

   Demonstration of non-degradative TRiC/CCT ubiquitination revealed a second mode of DCAF12 action that enhances chaperonin folding and drives YAP/STAT3/mTOR signaling and lung cancer metastasis.

   Evidence Knockdown with in vitro/in vivo metastasis assays, ubiquitination assays, pathway activation readouts, HSF1A inhibition

   PMID:41047465

   Open questions at the time

   • Ubiquitin linkage type and how it avoids degradation not defined
   • Reconciliation with degradative CCT5 regulation unclear
   • Single lab
10. 2022 Medium

    Human DCAF12 was shown to antagonize IAPs directly by BIR-domain binding and apoptosis-induced nucleocytoplasmic translocation, mechanizing the apoptotic role first seen in flies and adding NF-κB suppression.

    Evidence Co-IP with multiple IAPs, subcellular fractionation upon apoptotic stimuli, BIR domain mapping, caspase and NF-κB assays

    PMID:35459779

    Open questions at the time

    • Whether this is independent of ubiquitin ligase activity not fully resolved
    • Trigger of translocation not defined
    • Single lab

• How DCAF12 toggles between degradative and non-degradative ubiquitination, and between ligase-dependent and IAP-antagonist roles, and what governs its substrate repertoire in different tissues, remains unresolved.
• No unifying model for choice of ubiquitin outcome
• Regulation of substrate selection across contexts unknown
• Mechanistic basis of nuclear-cytoplasmic shuttling uncharacterized